A shadow market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.
Investigational Drug Gaining Traction Online
Retatrutide, which is still in research studies, is being promoted by online personalities for its alleged weight-reducing properties. Viewers are urged to message these accounts directly for supplier links, while also receiving promotional offers.
Active Trade on Messaging Platforms
Additionally, a robust trade exists on messaging services, where communities with numerous of members share comparison images, injection guides and claims of rapid UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Professionals Express Worries
Nevertheless, physicians and chemists have warned that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals injecting products of unknown origin.
Some experts said the popularity for the experimental drug could be linked to the rising cost of approved weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, legal action or imprisonment.
Service Reaction and Content Elimination
According to TikTok, the service has removed problematic material and banned associated keywords and search suggestions. The company stated it was committed to maintaining the platform secure and allocating resources in strengthening compliance measures.
Digital Trading Operations
Investigations also discovered communities with up to 9,000 participants selling the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays channels with numerous of users, populated with photos of slimming results, glowing reviews and step-by-step guides for preparing or administering at residence.
Within minutes of entering one group, a vendor posted WhatsApp details, where the majority of purchases take place. The seller sent an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about body mass, health issues or past usage.
Product Information and Costs
Within these communities, posts display black plastic packages with postal service labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with sterile water, or pre-filled injectors typically sold at 160 pounds for 20mg. When asked how much time a pen should be used, sellers give conflicting responses varying between a several days to “depends on your body”.
Platform Oversight and Safety Actions
A representative for the messaging service said it actively monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering materials they can’t verify. Even if the research behind retatrutide is valid, these online products may not include what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in demand to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.
Her team has already seen individuals harmed by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a company investigational substance not yet authorized … may expose users to potentially significant medical dangers”.
